Unique ID issued by UMIN | UMIN000019202 |
---|---|
Receipt number | R000022200 |
Scientific Title | Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients. |
Date of disclosure of the study information | 2015/10/01 |
Last modified on | 2017/10/30 10:25:38 |
Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.
Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.
Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.
Clinical study of sensory evaluation using Olmesartan orally disintegrating tablet (OD tablets) for hypertensive patients.
Japan |
Hypertension
Cardiology |
Others
NO
Sensory evaluation are conducted by taking Olmesartan OD tablets 20mg 1 tablet / day for hypertensive patients using Olmesartan tablets 20mg.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
Evaluation of sensory
Evaluation of safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Hypertensive patients using Olmesartan tablets 20mg take Olmesartan OD tablets 20mg.Intervention period : 1 day
20 | years-old | <= |
Not applicable |
Male and Female
1) Patients who are 20 years of age or older at the moment obtaining informed consent.
2) Patients who are already taking Olmesartan tablets 20mg from before more than two weeks of obtaining informed consent.
3) Patients who provided voluntary informed consent to participate in the study after receiving sufficient explanation.
1) Patients who are taking dementia therapeutics.
2) Patients who are a history of hypersensitivity to Olmesartan tablet.
3) Diabetic patients who are taking aliskiren fumarate(Except for uncontrolled patients of blood pressure by doing other antihypertensive treatment.)
4) Patients who are pregnant or during lactation, or there is becoming the possibility of pregnant.
5) Patients who jugged unsuitable for this study by the investigator.
30
1st name | |
Middle name | |
Last name | Harunori Oda |
Medical corporation Ishinkai
Oda clinic
Medecine Gastroenterological medicine Surgery
Daito Building 2F, 1-11-3, Okubo
03-5273-0770
odaclinic@ishinkai-mc.net
1st name | |
Middle name | |
Last name | Kotaro Senuki |
Sogo Rinsho Médéfi Co,Ltd.
Business Promotion Department
9F KDX Shinjuku Building 3-2-7 Nishi Shinjuku
03-6901-6079
OLM-OD@sogo-medefi.jp
Medical corporation Ishinkai
Oda clinic
Daiichi Sankyo Company, Limited
Profit organization
Japan
NO
医療法人社団医進会 小田クリニック
2015 | Year | 10 | Month | 01 | Day |
Published
Completed
2015 | Year | 08 | Month | 05 | Day |
2015 | Year | 10 | Month | 13 | Day |
2015 | Year | 11 | Month | 12 | Day |
2015 | Year | 12 | Month | 02 | Day |
2015 | Year | 10 | Month | 01 | Day |
2017 | Year | 10 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022200
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |